# Angel Biomedical Limited (07999919)

> Why UK company 07999919 went into administration, from the administrators' statement filed at Companies House, by companydig. Interactive version: https://companydig.co.uk/company/07999919

- **Status:** Administration ended
- **Administration began:** 2013-02-08
- **Administrators:** Gary Steven Fraser, Blair Carnegie Nimmo
- **Administrators' firm:** KPMG
- **Incorporated:** 2012-03-21
- **Location:** London

## Why it went into administration

- Funding withdrawn / unable to refinance
- Cash flow / liquidity pressure
- Sustained trading losses

## From the administrators' statement

ABL was incorporated on 21 Match 2012 and its principal activity was the manufacture and supply of clinically-based bio-mateals for globa! biotechnology and pharmaceutical companies ABL had one employee and operated from a 1ented facility in Glasgow.

Since incorpoiation ABL had been developing medical grade collagen products The Company had not yet obtained the necessary ceitification to sell these products and the facility was not producing any revenue

The parent company, Angel Biotechnology Holdings plc, had incurred losses as a tesult of difficult trading conditions and contactual difficulties This led to cash flow difficulties and the Directors were unable to obtain additional funding The Duectois of ABH resolved to appomt administiators on 8 February 2013.

Statement of proposals: https://find-and-update.company-information.service.gov.uk/company/07999919/filing-history/MzA3NjA5MTAxOGFkaXF6a2N4/document?format=pdf&download=0
Companies House register: https://find-and-update.company-information.service.gov.uk/company/07999919

Contains public sector information from Companies House, licensed under the Open Government Licence v3.0.
